Von Willebrand disease

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 7, Issue 6, 2007, Pages 629-632

  Wilde, Jonathan T ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN;

DISEASE CLASSIFICATION; HUMAN; REVIEW; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASE TYPE 1; VON WILLEBRAND DISEASE TYPE 2A; VON WILLEBRAND DISEASE TYPE 2B; VON WILLEBRAND DISEASE TYPE 2M; VON WILLEBRAND DISEASE TYPE 2N;

EID: 37149013330     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.7-6-629     Document Type: Review

References (11)

1. Sadler JE, Mannucci PM, Berntorp E et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84:160-74.
2. Sadler JE. Biochemistry and genetics of von Willebrand factor. Review. Annu Rev Biochem 1998;67:395-424.
3. Ruggeri ZM. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Review. Best Pract Res Clin Haematol 2001;14:257-79.
4. Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994;71: 520-5.
5. Sadler JE, Budde U, Eikenboom JC et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. Review. J Thromb Haemost 2006;4:2103-14.
6. Laffan M, Brown SA, Collins PW et al. The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 2004; 10:199-217.
7. Cumming A, Grundy P, Keeney S et al. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Thromb Haemost 2006;96:630-41.
8. Pasi KJ, Collins PW, Keeling DM et al. Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 2004;10:218-31.
9. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Review. Blood 1997;90:2515-21.
10. Lillicrap D, Poon MC, Walker I et al. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P:ristocetin cofactor unit dosing in patients with von Willebrand disease. Thromb Haemost 2002;87:224-30.
11. Mannucci PM, Chediak J, Hanna W et al. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. Blood 2002;99:450-6.